Enhanced p-tau expression is often observed in the later phases of MS, and it might result from the prion-like self-replication of p-tau molecules, causing the spread of the neurodegenerative processes, independent of the initial inflammatory triggers [25]. Here, MAPT is linked to myeloid sarcoma.